Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Sarmistha Majumdar, Francesco Di Palma, Francesca Spyrakis, Sergio Decherchi & Andrea Cavalli. (2023) Molecular Dynamics and Machine Learning Give Insights on the Flexibility–Activity Relationships in Tyrosine Kinome. Journal of Chemical Information and Modeling 63:15, pages 4814-4826.
Crossref
Crossref
Jintong Na, Xiyu Liu, Xinjun Sun, Dianfa Fan, Zhangbo Qian, Min Yao, Lina Pan, Ziqing He, Qiaoqiao Liu, Zhen Shen, Rong Jiao, Xia Lin, Lu Gan, Guiyin Li & Liping Zhong. (2023) Anlotinib: A Novel Molecular-Targeted Drug for Tumours. Journal of Biomedical Nanotechnology 19:6, pages 897-918.
Crossref
Crossref
Haofan Zhang, Fengming He, Guiping Gao, Sheng Lu, Qiaochu Wei, Hongyu Hu, Zhen Wu, Meijuan Fang & Xiumin Wang. (2023) Approved Small-Molecule ATP-Competitive Kinases Drugs Containing Indole/Azaindole/Oxindole Scaffolds: R&D and Binding Patterns Profiling. Molecules 28:3, pages 943.
Crossref
Crossref
Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, J. Luis Espinoza, Hirokazu Tanaka, Hitoshi Hanamoto & Itaru Matsumura. (2022) Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and Biophysical Research Communications 626, pages 156-166.
Crossref
Crossref
Jingman Xu, Xiyun Bian, Huanhuan Zhao, Yujie Sun, Yanyi Tian, Xiaodong Li & Wei Tian. (2021) Morphine Prevents Ischemia/Reperfusion-Induced Myocardial Mitochondrial Damage by Activating δ-opioid Receptor/EGFR/ROS Pathway. Cardiovascular Drugs and Therapy 36:5, pages 841-857.
Crossref
Crossref
Galina Sufianova, Ilgiz Gareev, Ozal Beylerli, Jianing Wu, Alina Shumadalova, Albert Sufianov, Xin Chen & Shiguang Zhao. (2022) Modern aspects of the use of natural polyphenols in tumor prevention and therapy. Frontiers in Cell and Developmental Biology 10.
Crossref
Crossref
Rong Tang, Wallace Y. Langdon & Jian Zhang. (2022) Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases. Frontiers in Endocrinology 13.
Crossref
Crossref
Toheeb A. Balogun, Oluwasegun M. Ige, Abdullahi O. Alausa, Chijioke O. Onyeani, Zainab A. Tiamiyu, Damilola A. Omoboyowa, Oluwatosin A. Saibu & Olayemi T. Abdullateef. (2021) Receptor tyrosine kinases as a therapeutic target by natural compounds in cancer treatment. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
Ting Guo & Shutao Ma. (2020) Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents. ChemMedChem 16:4, pages 600-620.
Crossref
Crossref
Belgin Sever, Mehlika Dilek Altıntop, Ahmet Özdemir, Gülşen Akalın Çiftçi, Doha E. Ellakwa, Hiroshi Tateishi, Mohamed O. Radwan, Mahmoud A. A. Ibrahim, Masami Otsuka, Mikako Fujita, Halil I. Ciftci & Taha F. S. Ali. (2020) In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules 25:21, pages 5190.
Crossref
Crossref
Priya Nijhawan, Tapan Behl & Sandeep Arora. (2020) Role of Protein Kinase C in obesity. Obesity Medicine, pages 100207.
Crossref
Crossref
Taha Azad, Kazem Nouri, Helena J. Janse van Rensburg, Sarah M. Maritan, Liqing Wu, Yawei Hao, Tess Montminy, Jihang Yu, Prem Khanal, Lois M. Mulligan & Xiaolong Yang. (2019) A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis. Oncogene 39:2, pages 334-355.
Crossref
Crossref
Revathy Nadhan, Priya Srinivas & M. Radhakrishna Pillai. 2020. Receptor Tyrosine Kinases. Receptor Tyrosine Kinases
319
373
.
Sarah Mele & Travis K. Johnson. (2019) Receptor Tyrosine Kinases in Development: Insights from Drosophila. International Journal of Molecular Sciences 21:1, pages 188.
Crossref
Crossref
Caixia An, Hailong Li, Xueyan Zhang, Jing Wang, Yi Qiang, Xinhua Ye, Qiang Li, Quanlin Guan & Yongning Zhou. (2019) Silencing of COPB2 inhibits the proliferation of gastric cancer cells and induces apoptosis via suppression of the RTK signaling pathway. International Journal of Oncology.
Crossref
Crossref
Michele Ghidini, Jens C. Hahne, Melissa Frizziero, Gianluca Tomasello, Francesco Trevisani, Andrea Lampis, Rodolfo Passalacqua & Nicola Valeri. (2018) MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours. Targeted Oncology 13:4, pages 423-436.
Crossref
Crossref
Mohammed I. El-Gamal, Shahad K. Al-Ameen, Dania M. Al-Koumi, Mawadda G. Hamad, Nouran A. Jalal & Chang-Hyun Oh. (2018) Recent Advances of Colony-Stimulating Factor-1 Receptor (CSF-1R) Kinase and Its Inhibitors. Journal of Medicinal Chemistry 61:13, pages 5450-5466.
Crossref
Crossref
Kenneth S. Chen, Nicholas J. Fustino, Abhay A. Shukla, Emily K. Stroup, Albert Budhipramono, Christina Ateek, Sarai H. Stuart, Kiyoshi Yamaguchi, Payal Kapur, A. Lindsay Frazier, Lawrence Lum, Leendert H.J. Looijenga, Theodore W. Laetsch, Dinesh Rakheja & James F. Amatruda. (2018) EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors. Molecular Cancer Therapeutics 17:5, pages 1079-1089.
Crossref
Crossref
Stine Gerdøe-Kristensen, Viktor K. Lund, Hans H. Wandall & Ole Kjaerulff. (2017) Mactosylceramide prevents glial cell overgrowth by inhibiting insulin and fibroblast growth factor receptor signaling. Journal of Cellular Physiology 232:11, pages 3112-3127.
Crossref
Crossref
Parunya Chaiyawat, Jeerawan Klangjorhor, Jongkolnee Settakorn, Voraratt Champattanachai, Areerak Phanphaisarn, Pimpisa Teeyakasem, Jisnuson Svasti & Dumnoensun Pruksakorn. (2017) Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma. Translational Oncology 10:5, pages 846-853.
Crossref
Crossref
Qiaoling Song, Xiaoxiao Sun, Hui Guo & Qiang Yu. (2016) Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells. Oncotarget 8:3, pages 5003-5015.
Crossref
Crossref
Atilla Engin. 2017. Obesity and Lipotoxicity. Obesity and Lipotoxicity
111
134
.
Omid Zarei, Silvia Benvenuti, Fulya Ustun-Alkan, Maryam Hamzeh-Mivehroud & Siavoush Dastmalchi. (2016) Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery. Journal of Cancer Research and Clinical Oncology 142:12, pages 2429-2446.
Crossref
Crossref
Scott E. Woodman. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research
347
352
.
Tom T. Chen, Ellen Filvaroff, Jing Peng, Scot Marsters, Adrian Jubb, Hartmut Koeppen, Mark Merchant & Avi Ashkenazi. (2015) MET Suppresses Epithelial VEGFR2 via Intracrine VEGF-induced Endoplasmic Reticulum-associated Degradation. EBioMedicine 2:5, pages 406-420.
Crossref
Crossref
Astrid A. Glück, Daniel M. Aebersold, Yitzhak Zimmer & Michaela Medová. (2015) Interplay between receptor tyrosine kinases and hypoxia signaling in cancer. The International Journal of Biochemistry & Cell Biology 62, pages 101-114.
Crossref
Crossref
Huimin Hu, Yanwei Liu & Tao Jiang. (2015) Mutation-introduced dimerization of receptor tyrosine kinases: from protein structure aberrations to carcinogenesis. Tumor Biology 36:3, pages 1423-1428.
Crossref
Crossref
Hiroshi Fushiki, Yoshihiro Murakami, Sosuke Miyoshi & Shintaro Nishimura. 2015. Apoptosis and Cancer. Apoptosis and Cancer
199
206
.
Orit Jacobson & Xiaoyuan Chen. (2013) Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics. Pharmacological Reviews 65:4, pages 1214-1256.
Crossref
Crossref
Lei Ding, Feng Tang, Wei Huang, Qiu Jin, Han Shen & Ping Wei. (2013) Design, synthesis, and biological evaluation of novel 3-pyrrolo[b]cyclohexylene-2-dihydroindolinone derivatives as potent receptor tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters 23:20, pages 5630-5633.
Crossref
Crossref
Stephen F Madden, Colin Clarke, Patricia Gaule, Sinead T Aherne, Norma O'Donovan, Martin Clynes, John Crown & William M Gallagher. (2013) BreastMark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome. Breast Cancer Research 15:4.
Crossref
Crossref
LU JIANG, YONGCHANG CHEN, JIANRONG SANG, YUEYING LI, TING LAN, YING WANG, YAN TAO & HAI QIAN. (2013) Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells. Biomedical Reports 1:3, pages 399-404.
Crossref
Crossref
Eduardo Ferrero, María Dolores Mauricio, Miriam Granado, Oscar García-Villar, Martín Aldasoro, José María Vila, Manuel Hidalgo, Jorge Luis Ferrero, Nuria Fernández, Luis Monge & Ángel Luis García-Villalón. (2013) Tyrosine Phosphorylation Modulates the Vascular Responses of Mesenteric Arteries from Human Colorectal Tumors. BioMed Research International 2013, pages 1-8.
Crossref
Crossref
Kenneth Verstraete & Savvas N. Savvides. (2012) Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases. Nature Reviews Cancer 12:11, pages 753-766.
Crossref
Crossref